
Tirzepatide
An injectable treatment that acts on GIP and GLP-1 pathways involved in appetite and fullness, with treatment decisions guided by a licensed provider.

Tirzepatide
CompoundedWhy patients choose this option
- Acts on both GIP and GLP-1 receptor pathways
- Supports signals involved in hunger and fullness
- Treatment eligibility and dosing determined by a licensed provider
Select your plan
Dosage and final treatment eligibility are determined by your licensed provider after checkout.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
At a glance
Injection
Use as prescribed by your provider
GIP + GLP-1
Two receptor pathways
Provider-reviewed
Eligibility and dosing
Member portal
Medical intake after checkout
How it works
From checkout to care, step by step.
Choose & check out
Pick your plan length and complete secure payment.
Access your portal
You'll receive email/text instructions to access your Faith Bridge Health member portal.
Complete your intake
Complete your medical intake in the member portal after checkout. A licensed provider reviews it and determines whether treatment is appropriate before medication is prescribed.
Product information
Tirzepatide is an injectable medication that acts on GIP and GLP-1 receptors. If treatment is prescribed, follow your provider's instructions for your specific formulation, dose and schedule. Share your health history and current medications with your provider and discuss precautions and possible side effects before use. This general overview does not replace the instructions or safety information provided with your prescription.
It might also interest you

Compounded
Semaglutide
A once-weekly GLP-1 injection that helps regulate appetite and fullness, with dosing guided by a licensed provider.
Explore Semaglutide